article thumbnail

California Legislature Takes Another Swing at Private Equity Participation in Healthcare

JD Supra: Mergers

Last fall, private equity and hedge fund investors were given a reprieve from the prospect of increased oversight of healthcare transactions when California Governor Gavin Newsom unexpectedly vetoed Assembly Bill 3129 (AB 3129). By: Husch Blackwell LLP

article thumbnail

Massachusetts Tightens Healthcare Transaction Oversight, Focuses on Healthcare Investors

JD Supra: Mergers

The Act increases regulatory reporting obligations and oversight of healthcare transactions involving private equity sponsors, healthcare real estate investment trusts (REITs) and management services organizations (MSOs). Maura Healy signed An Act Enhancing the Market Review Process (the Act). By: McGuireWoods LLP

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthcare Trends & Transactions Q2 2024

JD Supra: Mergers

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their “dry powder.”.

article thumbnail

2024 Healthcare Private Equity Outlook & Trends

JD Supra: Mergers

As we begin 2024, we have highlighted the issues and trends that private equity (PE) investors should consider when evaluating transactions in the healthcare sector. W ith various headwinds resulting in down volume in 2023, buyers and sellers alike find themselves asking whether 2024 will see a rebound in deal activity.

article thumbnail

Indiana Enacts Broad Notification Requirements for Healthcare Transactions with a Clear Focus on Private Equity

JD Supra: Mergers

Earlier this year, Indiana joined a growing number of states by enacting a new notification requirement for certain healthcare transactions.

article thumbnail

Supporting the Health of your Healthcare Organization

JD Supra: Mergers

Private equity sponsors and their healthcare portfolio companies are expected to ride the tailwind of an M&A rebound. As a result, sellers may be incentivized to explore market opportunities without requiring investors to gross-up purchase multiple premiums. By: DLA Piper

article thumbnail

Healthcare Private Equity: What to Expect for the Rest of 2024

JD Supra: Mergers

healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. Although the U.S. Dry powder held by U.S.